Yuriy Pomeshchik

Affiliations: 
Lund University, Lund, Skåne län, Sweden 
Google:
"Yuriy Pomeshchik"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Korhonen P, Pollari E, Kanninen KM, et al. (2019) Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis. Ibro Reports. 6: 74-86
Gustavsson N, Marote A, Pomeshchik Y, et al. (2018) Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene. Stem Cell Research. 34: 101373
Marote A, Pomeshchik Y, Collin A, et al. (2018) Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene. Stem Cell Research. 28: 44-47
Marote A, Pomeshchik Y, Goldwurm S, et al. (2018) Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene. Stem Cell Research. 27: 90-94
Marote A, Pomeshchik Y, Goldwurm S, et al. (2018) Generation of an integration-free induced pluripotent stem cell line (CSC-43J) from a patient with sporadic Parkinson's disease. Stem Cell Research. 27: 82-85
Savchenko E, Marote A, Russ K, et al. (2018) Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease. Stem Cell Research. 27: 78-81
Russ K, Marote A, Savchenko E, et al. (2018) Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation. Stem Cell Research. 27: 61-64
Djelloul M, Azevedo C, Pomeshchik Y, et al. (2017) Reporting on methods to generate and purify rodent and human oligodendrocytes from different sources. Stem Cell Research. 20: 58-66
Huuskonen MT, Tuo QZ, Loppi S, et al. (2017) The Copper bis(thiosemicarbazone) Complex Cu(II)(atsm) Is Protective Against Cerebral Ischemia Through Modulation of the Inflammatory Milieu. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics
Lemarchant S, Dunghana H, Pomeshchik Y, et al. (2016) Anti-inflammatory effects of ADAMTS-4 in a mouse model of ischemic stroke. Glia. 64: 1492-507
See more...